Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Facial feminization surgery is safe and patients are satisfied, but more detailed research is needed.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Facial feminization surgery helps make facial features more feminine, improving patient satisfaction and safety.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Affected males are born with ambiguous genitalia, raised as females, but develop male traits at puberty due to enzyme deficiency.

Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.

More research is needed to improve lower body gender affirmation techniques.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Alopecia in transgender individuals on hormone therapy can worsen emotional distress and affect self-esteem.

Testosterone therapy improved symptoms in a woman with congenital adrenal hyperplasia.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Managing menopause symptoms like skin changes and hair thinning involves hormone therapy, procedures, and skincare, with emotional support being important.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Hormone therapy can improve sexual health and quality of life for women 70 and older.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Medication can effectively reduce hair growth and improve life quality for women with hirsutism.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Finasteride helps reduce hidradenitis suppurativa symptoms in females.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.